The place for remdesivir in COVID-19 treatment

Lancet Infect Dis. 2021 Jan;21(1):20-21. doi: 10.1016/S1473-3099(20)30911-7. Epub 2020 Nov 26.
No abstract available

Publication types

  • Comment

MeSH terms

  • Adenosine Monophosphate / analogs & derivatives
  • Adult
  • Alanine / analogs & derivatives
  • COVID-19* / drug therapy
  • Double-Blind Method
  • Humans
  • SARS-CoV-2

Substances

  • remdesivir
  • Adenosine Monophosphate
  • Alanine

Supplementary concepts

  • COVID-19 drug treatment

Associated data

  • ClinicalTrials.gov/NCT03684044
  • ClinicalTrials.gov/NCT03376321